This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tonghua Dongbao Pharmaceutical Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Xindan Fan: Innovator in Pharmaceutical Solutions
Introduction
Xindan Fan is a notable inventor based in Jilin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable drug formulations. His work is characterized by a commitment to improving the quality and stability of pharmaceutical products.
Latest Patents
Xindan Fan holds a patent for a stable secukinumab injection and its preparation method. This innovative formulation includes 50 mg/ml-300 mg/ml of secukinumab, along with histidine, methionine, a low-sugar alcohol, and polysorbate 80, with water for injection as the balance. The pH of the solution is maintained between 5.0 and 7.0. Stability tests have demonstrated that this injection maintains superior quality compared to commercial varieties available in the market. The formulation meets the relevant regulations of the Chinese Pharmacopoeia and shows promising application prospects.
Career Highlights
Xindan Fan is associated with Tonghua Dongbao Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical innovations. His expertise in drug formulation has contributed to the company's reputation for quality and reliability in the pharmaceutical industry.
Collaborations
Xindan collaborates with talented colleagues, including Nan Zhang and Chunsheng Leng. Their combined efforts enhance the research and development capabilities of their organization.
Conclusion
Xindan Fan's contributions to pharmaceutical innovations, particularly through his patent for a stable secukinumab injection, highlight his role as a key inventor in the industry. His work not only advances drug stability but also aligns with regulatory standards, ensuring better healthcare solutions.